Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study

Budoff, M; Muhlestein, JB; Le, VT; May, HT; Roy, S; Nelson, JR

Nelson, JR (reprint author), Calif Cardiovasc Inst, 7061 N Whitney,Suite 101, Fresno, CA 93720 USA.

CLINICAL CARDIOLOGY, 2018; 41 (1): 13

Abstract

Despite reducing progression and promoting regression of coronary atherosclerosis, statin therapy does not fully address residual cardiovascular (CV) ......

Full Text Link